Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Galapagos
Galapagos
Gilead Takes Lead on Crohn's over AbbVie
Investopedia
Mon, 11/28/16 - 11:33 pm
Gilead Sciences
AbbVie
Crohn's Disease
Galapagos
filgotinib
ABT-494
Gilead May Not Acquire Galapagos, For Now (GILD, GLPG)
Investopedia
Thu, 09/29/16 - 08:16 am
Gilead Sciences
Galapagos
Will Gilead (GILD) Stock Be Helped by Positive Crohn's Drug Results?
TheStreet.com
Mon, 09/26/16 - 03:25 pm
Gilead Sciences
Crohn's Disease
filgotinib
Galapagos
Why AbbVie Won't Pull A Galapagos On Ablynx
Seeking Alpha
Tue, 08/30/16 - 09:47 am
AbbVie
Galapagos
Ablynx
vobarilizumab
AbbVie adds $250M in milestones to Galapagos cystic fibrosis deal
Fierce Biotech
Thu, 05/5/16 - 02:08 pm
AbbVie
Galapagos
cystic fibrosis
J&J sells 5% stake in Galapagos after Gilead usurps it as largest shareholder
Fierce Biotech
Thu, 02/25/16 - 08:43 pm
JNJ
Gilead Sciences
Galapagos
Gilead Takes a Page Out of Celgene's Playbook
Motley Fool
Sat, 01/23/16 - 12:51 pm
Gilead Sciences
Celgene
Galapagos
M&A
filgotinib
Galapagos moves AbbVie-partnered drug into PhI as multipronged attack on CF takes shape
Fierce Biotech
Sat, 01/23/16 - 11:06 am
Galapagos
AbbVie
GLPG2222
cystic fibrosis
Reviewing Gilead's Latest Pipeline News: Focus On Oncology And The Galapagos Deal
Seeking Alpha
Fri, 01/1/16 - 08:35 pm
Gilead Sciences
oncology
R&D
Galapagos
Gilead joins Pfizer and Eli Lilly in JAK Race
Bidness, ETC
Sun, 12/27/15 - 10:24 am
Gilead Sciences
JAK inhibitors
Pfizer
Eli Lilly
filgotinib
Galapagos
Xeljanz
baricitinib
Are Gilead Sciences, AstraZeneca Deals a Threat to AbbVie?
Bidness, ETC
Sun, 12/20/15 - 04:45 pm
Gilead Sciences
AstraZeneca
AbbVie
filgotinib
Acerta Pharma
Galapagos
Belgium's Galapagos signs $2 bln deal with U.S. company Gilead
Yahoo/Reuters
Thu, 12/17/15 - 09:50 am
Belgium
Galapagos
Gilead Sciences
filgotinib
R&D
AstraZeneca, Gilead Drug License Deals Could Pinch AbbVie Growth
TheStreet.com
Thu, 12/17/15 - 09:40 am
AstraZeneca
Gilead Sciences
AbbVie
Acerta Pharma
Galapagos
Why Amgen Can Acquire Galapagos NV?
Bidness, ETC
Wed, 12/9/15 - 09:38 am
Amgen
Galapagos
M&A
Galapagos' inflammation drug comes through in Crohn's with Phase III in sight
Fierce Biotech
Tue, 12/8/15 - 10:54 pm
Galapagos
Crohn's Disease
filgotinib
AbbVie dumps Galapagos' arthritis drug and presses on with its own
Fierce Biotech
Fri, 09/25/15 - 10:13 am
AbbVie
Galapagos
rheumatoid arthritis
ABT-494
JAK inhibitors
What’s Wrong With Vertex?
Barron's
Fri, 09/18/15 - 09:11 pm
Vertex Pharmaceuticals
ProQR Therapeutics
Galapagos
Galapagos starts timer on AbbVie buy-in decision with posting of final data
Fierce Biotech
Fri, 08/14/15 - 09:20 am
Galapagos
AbbVie
JAK inhibitors
rheumatoid arthritis
filgotinib
Galapagos peaks as AbbVie hype builds, Shorts target Bavarian, MorphoSys makes GPCR play
Fierce Biotech
Fri, 08/7/15 - 10:44 am
Galapagos
AbbVie
Bavarian Nordic
Intec Pharma
MorphoSys
Galapagos leases one-third of Sanofi-founded biopark to consolidate French R&D operations
Fierce Biotech
Fri, 06/5/15 - 09:22 am
R&D
Galapagos
Sanofi
France
Pages
« first
‹ previous
1
2
3
4
5
6
7
next ›
last »